VC:BRANDONCAPITAL
Ena Respiratory
- Privately Held
locale
Australiamarket
PRIVATEindustry
Biotechnologywebsite
brandoncapital.vccrunchbase
innavaclinkedin
brandon-capitalfounding date
Jan 01, 2007
Ena Respiratory is a biotech company specializing in the development of a first-in-class prophylactic intranasal antiviral innate immunomodulator, INNA-051, aimed at preventing respiratory infections such as COVID-19 and influenza.